Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-045922
Filing Date
2011-08-12
Accepted
2011-08-12 12:07:26
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v230115_10q.htm 10-Q 555909
2 v230115_ex31-1.htm EX-31.1 19343
3 v230115_ex31-2.htm EX-31.2 19553
4 v230115_ex32-1.htm EX-32.1 9562
5 v230115_ex32-2.htm EX-32.2 9307
  Complete submission text file 0001144204-11-045922.txt   1925355

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20110630.xml EX-101.INS 197105
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20110630.xsd EX-101.SCH 12112
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20110630_cal.xml EX-101.CAL 26728
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20110630_def.xml EX-101.DEF 52983
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20110630_lab.xml EX-101.LAB 121745
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20110630_pre.xml EX-101.PRE 70248
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 111030058
SIC: 2834 Pharmaceutical Preparations